Pharma & Biotech VC & Investment News
Biotechnology
Danish life sciences investor Novo Holdings is continuing the spread of its cash pile, this time as co-leader of a $181.4 million Series D financing in Alentis Therapeutics. 12 November 2024
Today's issue
Refine Search
Biotechnology
Launched in February 2019 with $60 million financing, US biotech HiberCell today announced that it has completed a Series B financing round for gross proceeds of $67.4 million. 20 May 2021
Biotechnology
Singapore-based clinical-stage biotech Hummingbird Bioscience today announced the close of its $125 million Series C financing round. 18 May 2021
Biotechnology
Texas, USA-based molecular science and artificial intelligence (AI) focused Caris Life Sciences has announced an $830 million growth equity round at a post-money valuation of $7.83 billion. 14 May 2021
Biotechnology
Life sciences investment group Abingworth has announced the final closing of its new Clinical Co-Development Fund at $582 million. 10 May 2021
Biotechnology
Eikon Therapeutics, a pioneer in live-cell super-resolution microscopy and engineering for drug discovery, today announced that it has closed a $148 million Series A financing led by The Column Group with participation from Foresite Capital, Innovation Endeavors and Lux Capital. 5 May 2021
Biotechnology
USA-based Cocrystal Pharma saw its shares rocket 73% to $2.14 by close of trading yesterday, after it announced progress in developing broad-spectrum antiviral drug candidates that target coronaviruses including SARS-CoV-2, the coronavirus that causes COVID-19. 5 May 2021
Biotechnology
Spanish plasma specialist Grifols is to establish a global R&D hub in Andorra, focused on the human immune system and the potential for novel immune therapies. 28 April 2021
Biotechnology
Guernsey and Switzerland based Pureos Bioventure has announces the final closing of its first fund BB Pureos Bioventures LP with a committed capital of $205 million. 22 April 2021
Pharmaceutical
UK endocrine diseases specialist Diurnal today said it has raised £20 million ($28 million) through a placing to fund the company’s pivotal Phase III trial for Efmody (hydrocortisone modified-release hard capsules), a drug formerly known as Chronocort, as a treatment for congenital adrenal hyperplasia in the US through to registration. 21 April 2021
Biotechnology
Global non-profit partnership CARB-X is funding privately-held UK company Phico Therapeutics to develop a new intravenous engineered bacteriophage drug to treat ventilator-associated pneumonia caused by Pseudomonas aeruginosa. 19 April 2021
Biotechnology
US biotech Adagio Therapeutics says it has completed a $336 million Series C financing led by RA Capital Management, with participation from new investors, including Redmile Group, Federated Hermes, Foresite Capital, ArrowMark Partners, PremjiInvest, and another leading healthcare investor. 19 April 2021
Biotechnology
For biotech companies, the prospect of receiving non-dilutive, non-recourse funding to advance their assets even through the early stages of clinical development may sound too good to be true. 16 April 2021
Biotechnology
Cambridge, UK-based biotech Alchemab Therapeutics today announced the completion of a £60 million ($82 million) Series A financing round. 15 April 2021
Biotechnology
Clinical-stage US biotech Repertoire Immune Medicines today announced the completion of a $189 million Series B financing. 13 April 2021
Biotechnology
AELIS FARMA, a privately-held French biotech specializing in the treatment of brain disorders, has announced a boost for the Improving Cognition in Down Syndrome (ICOD) project. 9 April 2021
Biotechnology
US biotech Ventus Therapeutics today announced a $100 million Series B financing led by RA Capital Management, with the proceeds to be used to advance its pipeline of small-molecule medicines against traditionally undruggable targets. 8 April 2021
Biotechnology
Hutchison China MediTech, also known as Hutchmed, has announced a private placement of $100 million of funds from Baring Private Equity Asia (BPEA). 8 April 2021
Pharmaceutical
Multinational companies (MNCs) must evolve their strategies with a fast-paced China to succeed in the highly competitive market, said company representatives at the two-day 2021 China healthcare investment conference on March 24 in Shanghai. 6 April 2021
Biotechnology
Just two weeks after announcing a worldwide licensing agreement with Pfizer to develop and commercialize multiple antibody drug conjugates, Pyxis Oncology has announced a $152 million Series B financing. 30 March 2021
Biotechnology
Privately-held US biotech Omega Therapeutics has closed an upsized Series C financing of $126 million. 30 March 2021
Biotechnology
California-based venture capital firm Versant Ventures yesterday announced the launch of Pep2Tango Therapeutics, a start-up focused on innovative, next-generation weight loss therapies. Proceeds from the significant, undisclosed round will support development of the company’s novel unimolecular tetra-receptor agonist peptides to treat obesity and related conditions. 22 November 2024
Biotechnology
Hong Kong-based Sino Biopharm has signed an equity investment and strategic collaboration agreement with LaNova Medicines, advancing its oncology focus. 22 November 2024
Biotechnology
Colorado, USA-based biotech Enveda Biosciences, which is using AI to translate nature into new medicines, has announced an oversubscribed $130 million Series C funding round led by Kinnevik and FPV. 22 November 2024
Biotechnology
San Diego-based Cidara Therapeutics, a biotech using its proprietary Cloudbreak platform to develop drug-Fc conjugate (DFC) immunotherapies designed to save lives and improve the standard of care for patients facing serious diseases, has entered into a securities purchase agreement with certain investors to raise up to around $105 million. 21 November 2024
Biotechnology
Aizen Therapeutics, an AI-driven biotech headquartered in San Diego, has officially launched from stealth mode, introducing its drug discovery platform, DaX. 21 November 2024
Biotechnology
San Diego-based Valora Therapeutics, a biotech that boasts of having a novel approach to immunotherapy, has announced the successful closing of a $30 million seed funding round. 21 November 2024
article
The UK government has reappointed BioIndustry Association (BIA) chairman Daniel Mahony as its Life Sciences Investment Envoy. 21 November 2024
Pharmaceutical
Shanghai-based Leading Tac Pharmaceutical has announced the successful completion of a series A financing round, raising over 100 million yuan ($14 million). 21 November 2024
Biotechnology
A pair of industry veterans have teamed up to create Jupiter Bioventures, a San Francisco-based biotech venture foundry promised to build bold, science-driven therapeutics companies. 20 November 2024
Biotechnology
Aclaris Therapeutics has announced an exclusive licensing agreement with Biosion for broad rights to two new antibodies. 19 November 2024
Biotechnology
Californian oncology-focused biotech Avenzo Therapeutics has announced a pair of important updates. 19 November 2024
Pharmaceutical
In yet another sign of the mounting interest in radiopharmaceuticals, Tongrui Biopharma, a Chinese innovator in this area, has announced the completion of a $100 million series A+ financing round. 18 November 2024
Biotechnology
Shanghai-based biopharma Zai Lab has announced the pricing of its underwritten public offering at $25.50 per share, aiming to raise around $200 million. 15 November 2024
Pharmaceutical
New York-based Metsera, a biopharma developing medicines for obesity and metabolic diseases, has closed a $215 million Series B financing to further advance its portfolio of clinical-stage, nutrient-stimulated hormone (NuSH) analog peptides. 14 November 2024
Pharmaceutical
Life science investor Syncona has announced the launch of its newest portfolio company, Slingshot Therapeutics, through the Syncona Accelerator initiative. 14 November 2024
Biotechnology
Danish life sciences investor Novo Holdings is continuing the spread of its cash pile, this time as co-leader of a $181.4 million Series D financing in Alentis Therapeutics. 12 November 2024
Biotechnology
Trace Neuroscience, a newly launched biopharma based in San Francisco, aims to advance treatments for neurodegenerative diseases, starting with amyotrophic lateral sclerosis (ALS). 12 November 2024
Biotechnology
Geron Corporation, a biopharma company focused on telomerase inhibition therapies, has announced a $375 million financing agreement aimed at supporting the commercial rollout of Rytelo (imetelstat). 11 November 2024
Biotechnology
An Expert View from Cumulus Oncology about its innovative business model, which is all about improving the efficiency of drug R&D. 11 November 2024
Biotechnology
US biotech venture fund Aditum Bio and China’s Leads Biolabs today announced the formation of Oblenio Bio, marking the thirteenth company launched by Aditum. 7 November 2024
Sign up to receive email updates
Join industry leaders for a daily roundup of biotech & pharma news
Copyright © The Pharma Letter 2024 | Headless Content Management with Blaze